Abstract |
Thioredoxin 1 (Trx 1) is a 12-kDa protein with redox-active dithiol in the active site - Cys-Gly-Pro-Cys- that is ubiquitously present in the human body. Trx 1 is a defensive protein induced by various stresses and has anti-oxidative, anti-apoptotic and anti-inflammatory effects. The anti-oxidative effect of Trx 1 is mediated by the dithiol- disulfide exchange in the active site. Trx 1 is able to interact with certain molecules, one of which is thioredoxin-binding protein-2 ( TBP-2)/ Vitamin D3 upregulated protein 1 (VDUP1)/ thioredoxin interacting protein (TXNIP). TBP-2 was originally identified as a negative regulator of Trx 1 and acts as a cell growth suppressor and a regulator in lipid/ glucose metabolism. Trx 1 and TBP-2 play crucial roles in pathophysiological mechanisms in metabolic disorders, cancer and inflammation. Here we discuss pharmacological aspects of Trx 1 and TBP-2 in these diseases and propose potential therapeutic approaches for intractable oxidative stress-related disorders.
|
Authors | Rie Watanabe, Hajime Nakamura, Hiroshi Masutani, Junji Yodoi |
Journal | Pharmacology & therapeutics
(Pharmacol Ther)
Vol. 127
Issue 3
Pg. 261-70
(Sep 2010)
ISSN: 1879-016X [Electronic] England |
PMID | 20435060
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Copyright | 2010 Elsevier Inc. All rights reserved. |
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Antineoplastic Agents
- Carrier Proteins
- Recombinant Proteins
- TXNIP protein, human
- Thioredoxins
|
Topics |
- Animals
- Anti-Inflammatory Agents, Non-Steroidal
(pharmacology, therapeutic use)
- Antineoplastic Agents
(pharmacology, therapeutic use)
- Apoptosis
(drug effects, physiology)
- Carrier Proteins
(genetics, metabolism, physiology)
- Cell Proliferation
(drug effects)
- Humans
- Metabolic Diseases
(drug therapy, metabolism, pathology)
- Neoplasms
(drug therapy, metabolism, pathology)
- Oxidative Stress
(physiology)
- Recombinant Proteins
(genetics, pharmacology, therapeutic use)
- Thioredoxins
(genetics, metabolism, pharmacology, physiology, therapeutic use)
- Up-Regulation
|